Black Diamond Therapeutics Inc (BDTX)

Health Care · Biological Products, (No Diagnostic Substances)

Turbulence: Extreme Sector-strength: 64th pctile elevated vs peers

Black Diamond Therapeutics Inc sits in the Extreme turbulence band, around the 64th percentile of Health Care on balance-sheet strength. The lens reads it as elevated vs peers. The underlying figures, all from public filings:

Revenue (TTM) $70M
Net income (TTM) $22M
Operating margin 17.9%
FCF margin 42.3%
Altman Z n/a
Piotroski F 4
Beneish M n/a
Interest coverage n/a

See the full deep-dive in the app →

Figures from public filings (EDGAR). Descriptive, not advice. No targets, no buy or sell. Price and valuation live in the app.

Get the weekly read by email

The Filter covers the macro backdrop and where balance-sheet strength matters, in the same language as the page above. Descriptive only.

No spam, and the list is never sold or shared. Unsubscribe from any issue.